357
Views
13
CrossRef citations to date
0
Altmetric
Review

Innovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant Staphylococcus aureus: advances in phase I and II trials

, , &
Pages 495-506 | Received 25 Oct 2019, Accepted 30 Mar 2020, Published online: 19 Apr 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Daniele Roberto Giacobbe, Silvia Dettori, Silvia Corcione, Antonio Vena, Chiara Sepulcri, Alberto Enrico Maraolo, Francesco Giuseppe De Rosa & Matteo Bassetti. (2022) Emerging Treatment Options for Acute Bacterial Skin and Skin Structure Infections and Bloodstream Infections Caused by Staphylococcus aureus: A Comprehensive Review of the Evidence. Infection and Drug Resistance 15, pages 2137-2157.
Read now
Matteo Bassetti, Laura Labate, Monica Melchio, Chiara Robba, Denise Battaglini, Lorenzo Ball, Paolo Pelosi & Daniele Roberto Giacobbe. (2022) Current pharmacotherapy for methicillin-resistant Staphylococcus aureus (MRSA) pneumonia. Expert Opinion on Pharmacotherapy 23:3, pages 361-375.
Read now

Articles from other publishers (11)

Jie Fu, Xin Zong, Mingliang Jin, Junxia Min, Fudi Wang & Yizhen Wang. (2023) Mechanisms and regulation of defensins in host defense. Signal Transduction and Targeted Therapy 8:1.
Crossref
Thaila Fernanda dos Reis, Patrícia Alves de Castro, Rafael Wesley Bastos, Camila Figueiredo Pinzan, Pedro F. N. Souza, Suzanne Ackloo, Mohammad Anwar Hossain, David Harold Drewry, Sondus Alkhazraji, Ashraf S. Ibrahim, Hyunil Jo, Jorge D. Lightfoot, Emily M. Adams, Kevin K. Fuller, William F. deGrado & Gustavo H. Goldman. (2023) A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungi. Nature Communications 14:1.
Crossref
Anna Ramata-Stunda, Martins Boroduskis, Elza Kaktina, Liene Patetko, Uldis Kalnenieks, Zane Lasa, Marta Rubina, Inese Strazdina, Gints Kalnins & Reinis Rutkis. (2023) Comparative Evaluation of Existing and Rationally Designed Novel Antimicrobial Peptides for Treatment of Skin and Soft Tissue Infections. Antibiotics 12:3, pages 551.
Crossref
Ankita Parmanik, Soumyajit Das, Biswakanth Kar, Anindya Bose, Gaurav Raj Dwivedi & Murali Monohar Pandey. (2022) Current Treatment Strategies Against Multidrug-Resistant Bacteria: A Review. Current Microbiology 79:12.
Crossref
Wanxin Liang, Qian Yu, Zixian Zheng, Jiayong Liu, Qiongna Cai, Shouping Liu & Shuimu Lin. (2022) Design and Synthesis of Phenyl Sulfide-Based Cationic Amphiphiles as Membrane-Targeting Antimicrobial Agents against Gram-Positive Pathogens. Journal of Medicinal Chemistry 65:20, pages 14221-14236.
Crossref
Fiorinda F. Muhaj, Saira J. George & Stephen K. Tyring. (2022) Bacterial antimicrobial resistance and dermatological ramifications*. British Journal of Dermatology 187:1, pages 12-20.
Crossref
Siheng Wang, Chang Cai, Yingbo Shen, Chengtao Sun, Qingxin Shi, Ningjun Wu, Shufang Zheng, Jiao Qian, Rong Zhang & Hongwei Zhou. (2021) In vitro Activity of Contezolid Against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus, and Strains With Linezolid Resistance Genes From China. Frontiers in Microbiology 12.
Crossref
Daniele R. Giacobbe, Laura Labate, Antonio Vena & Matteo Bassetti. (2021) Potential role of new-generation antibiotics in acute bacterial skin and skin structure infections. Current Opinion in Infectious Diseases 34:2, pages 109-117.
Crossref
Victor B. Hsue, Kyohei Itamura, Arthur W. Wu, Elisa A. Illing, Kevin J. Sokoloski, Bree A. Weaver, Benjamin P. Anthony, Nathan Hughes, Jonathan Y. Ting & Thomas S. Higgins. 2021. Identification of Biomarkers, New Treatments, and Vaccines for COVID-19. Identification of Biomarkers, New Treatments, and Vaccines for COVID-19 169 189 .
Cecilia G. Carvalhaes, Leonard R. Duncan, Wen Wang & Helio S. Sader. (2020) In Vitro Activity and Potency of the Novel Oxazolidinone Contezolid (MRX-I) Tested against Gram-Positive Clinical Isolates from the United States and Europe . Antimicrobial Agents and Chemotherapy 64:11.
Crossref
Paul S. Hoffman. (2020) Antibacterial Discovery: 21st Century Challenges. Antibiotics 9:5, pages 213.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.